9-1-2021Cross-posted from NIAID newsroom No Safety Concerns Found in Imbokodo Sub-Saharan Africa StudyAn investigational HIV vaccine tested in the “Imbokodo” clinic…
8-19-2021Cross-posted from NIAID NewsroomThe National Institutes of Health has awarded approximately $53 million in annual funding over the next five years to 10 researc…
7-20-2021Adapted from National Institute of Allergy and Infectious Diseases emailPeople with HIV have significantly higher rates of cardiovascular disease than people wi…
7-8-2021Videos and posters are now available from the recent virtual National Ending the HIV Epidemic (EHE) Meeting of the NIH-funded Centers for AIDS Research (CFAR) a…
6-16-2021Cross-posted from NIH NewsroomA clinical trial is underway in five U.S. cities to determine whether delivering integrated health services through mobile clinics…
5-18-2021Cross-posted from NIAID Now blogWhile implementation of highly effective HIV treatment and prevention tools has reduced the HIV pandemic worldwide, development …
4-28-2021Cross-posted from NIAID Funding NewsDiagnose. Treat. Prevent. Respond.Such are the four pillars of the Ending the HIV Epidemic (EHE) initiative that represent k…
4-22-2021On Monday, May 10th the Office of Infectious Disease and HIV/AIDS Policy (OIDP) is holding a Live with Leadership conversation about how NIH-supported research …
4-9-2021Cross-posted from NIAID NewsroomThe COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and prevent…
3-11-2021As the 2021 virtual Conference on Retroviruses and Opportunistic Infections (CROI) concluded, NIH’s Dr. Carl Dieffenbach joined HIV.gov for a conversation abo…
